Gastrointestinal Adverse Events GI AEs are the most frequently reported side effects of GLP-1 RAs and, although typically mild, moderate, and transient, they remain the primary reason for treatment discontinuation among individuals with obesity receiving semaglutide [13, 27, 38, 40,41,42,43,44,45,46, 52]
Medical interventions should be deployed in tandem with policy decisions that address the environmental drivers of obesity and type 2 diabetes
Understanding Semaglutide: A GLP-1 Receptor Agonist Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist (a medication that mimics a natural hormone regulating blood sugar and appetite)
It whelps up just like this for 3-4 days and itches like crazy!" - u/Who-took-my-abs For many, the problem begins after several uneventful weeks
If phentermine is not tolerated, or if additional weight loss is needed (remember, on average Wegovy can help you lose ~15 pounds more than phentermine), Wegovy is a great option